Rare diseases
Investigational molecules
Locations
353 conditions with trials, the busiest first
844 trials across Europe, recruiting first
Study of Esflurbiprofen Hydrogel Patch Adhesion in Healthy Volunteers
GermanyPhase 1 study of remibrutinib exposure in cerebrospinal fluid after oral dosing in healthy participants
The NetherlandsA study testing TRIV-509 compared to placebo in adults with moderate to severe atopic dermatitis
BulgariaA study comparing how ritlecitinib capsules work when sprinkled on food versus swallowed whole and with or without food in healthy adults
BelgiumA study testing brepocitinib compared to placebo for adults with dermatomyositis to see if it works and is safe
BelgiumTesting delgocitinib cream for patients with vitiligo on the face
DenmarkA Study of Upadacitinib for Adults with Moderate to Severe Atopic Dermatitis Who Did Not Respond Well Enough to Dupilumab Treatment
ItalyA Study Testing Zasocitinib Compared to Placebo in Adults with Nonsegmental Vitiligo to See How Well It Works and How Safe It Is
FranceTesting IDOR-1117-2520 for Adults with Moderate to Severe Chronic Plaque Psoriasis With or Without Psoriatic Arthritis
BulgariaA study of immune system response in adults who develop shingles after receiving recombinant herpes zoster vaccine to understand vaccine protection
BelgiumStudy of BNT111 and cemiplimab in patients with advanced melanoma who have not responded to other therapies
GermanyA Study of Cizutamig for Patients with Severe Autoimmune Inflammatory Diseases That Did Not Respond to Previous Treatments
GermanyThe therapies tested most often in Skin and subcutaneous tissue disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
